FDA Delays Doribax, Rejecting Expert Advice Again

For the third time this month, the FDA has ignored a recommendation from outside experts to approve a marketing application for a drug. This time the setback was dealt to Johnson & Johnson’s intravenous antibiotic drug Doribax. The agency says it needs more information before it can decide on the use of Doribax to treat [...]